Printed from https://fyi.org.nz/request/26670-differences-between-bnt162b2-and-comirnaty on December 22, 2024 14:17

We don't know whether the most recent response to this request contains information or not – if you are ASE please sign in and let everyone know.

Differences between BNT162b2 and Comirnaty®

ASE made this Official Information request to Ministry of Health

This request has an unknown status. We're waiting for ASE to read a recent response and update the status.

From: ASE

Attn Ministry of Health,

I am seeking information regarding substantive differences between BNT162b2 and Comirnaty®.

Both products have variously been referred to as “COVID-19 vaccines” and “vaccine candidates”.

1- Are/were the same manufacturing processes used to manufacture Comirnaty® and BNT162b2? Has The Ministry of Health confirmed such information with the manufacturer/supplier?

2- What information is held by The Ministry of Health regarding similarities and differences between the manufacturing processes of BNT162b2 and Comirnaty®?

3- Are there any quantifiable differences between BNT162b2 and Comirnaty®, eg regarding the use or presence of SV40 sequences, the presence of DNA, the integrity of synthetic mRNA, the use of methyl-pseudouridine, or any other quantifiable differences?

Thank you,
ASE

Link to this

From: OIA Requests

Attachment image.png
89K Download

Kia ora

  

Thank you for your request for official information. The reference number
for your request is: H2024041059

  

As required under the Official Information Act 1982, Manatū Hauora will
endeavour to respond to your request no later than 20 working days after
the day your request was received. If you'd like to calculate the
timeframe, you can use the Ombudsman's online calculator
here: [1]http://www.ombudsman.parliament.nz/  

  

If you have any queries, please feel free to contact the OIA Services Team
on [2][email address]. If any additional factors come to light which
are relevant to your request, please do not hesitate to contact us so that
these can be taken into account.  

Under section 28(3) of the Act you have the right to ask the Ombudsman to
review any decisions made under this request. The Ombudsman may be
contacted by email at: [3][email address] or by calling 0800
802 602.

 

Ngā mihi 

 

OIA Services Team 

[4]Ministry of Health information releases 

 

 

------------------- Original Message

show quoted sections

Link to this

From: OIA Requests

Attachment Outlook g10nktar.png
80K Download

Attachment H2024041059 Response letter.pdf
166K Download View as HTML

Kia ora ASE,

 

Please find attached our response to your official information request.

 

Ngā mihi 

  

 

OIA Services Team

Manatū Hauora | Ministry of Health

M[1]inistry of Health information releases 
U[2]nite against COVID-19 

 

show quoted sections

References

Visible links
1. https://www.health.govt.nz/about-ministr...
2. https://covid19.govt.nz/

Link to this

We don't know whether the most recent response to this request contains information or not – if you are ASE please sign in and let everyone know.

Things to do with this request

Anyone:
Ministry of Health only: